Last reviewed · How we verify
NCT04664920
An Individualized Exergame Training Solution for People With Major Neurocognitive Disorder: a Usability Study
trial testing exergame in Major Neurocognitive Disorder in 22 participants. Completed in 25 September 2020.
25 September 2020
Quick facts
| Lead sponsor | Davy Vancampfort |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 22 |
| Start date | 8 June 2020 |
| Primary completion | 25 September 2020 |
| Estimated completion | 25 September 2020 |
| Sites | 1 location across Belgium |
Drugs / interventions tested
- exergame
Conditions studied
- Major Neurocognitive Disorder — all drugs for Major Neurocognitive Disorder →
- Physical Activity — all drugs for Physical Activity →
- Dementia — all drugs for Dementia →
Sponsor
Davy Vancampfort
Who can join
60 and older, any sex, with Major Neurocognitive Disorder or Physical Activity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to investigate the usability of a newly designed and developed user-centered exergame in older adults with major neurocognitive disorder (dementia).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The VITAAL Stepping Exergame Prototype for Older Adults With Major Neurocognitive Disorder: A Usability Study.
Swinnen N, de Bruin ED, Dumoulin C, Thalmann M, et al · · 2021 · cited 7× · PMID 34803650 · DOI 10.3389/fnagi.2021.701319
Verify or expand the search:
- PubMed search for NCT04664920
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of exergame
Trials testing the same drug.
- NCT06921057 — Effects of Exergames on Muscle and Lung Function in Elderly · NA · completed
- NCT04377191 — The Effect of Different Virtual Reality Trainings on Gait, Balance and Posture of Individuals With Dementia · NA · completed
- NCT04042896 — Effects of Exergame in Patients at High Cardiovascular Risk. · NA · completed
Other recruiting trials for Major Neurocognitive Disorder
Currently open trials in the same condition.
- NCT06701630 — Italian Adaptation and Validation of Functional and Behavioural Scales for Subjective Cognitive Decline, Mild Cognitive · recruiting
- NCT06631742 — Exergaming Revolution in Dementia · NA · recruiting
- NCT06615167 — Confirmatory Clinical Trial for Verifying the Efficacy and Safety of 'ALZGUARD' as a Digital Dementia Diagnostic Aid-Too · NA · recruiting
Other Davy Vancampfort trials
Trials by the same sponsor.
- NCT04436315 — Intervention Study of an Individualized Exergame Training for People With Major Neurocognitive Disorder · NA · unknown
- NCT04436302 — Exergaming in People With Major Neurocognitive Disorder · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04664920 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Davy Vancampfort
- Last refreshed: 11 December 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04664920.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing